Abstract DGI-057 Table 1

Antibiotics consumption (DDDs/100 bed-days)

	2002	2003	2004	2005	2006	2007	2008	2009	2010

Piperacillin- Tazobactam (P/T)	0.76	0.83	1.30	1.95	2.36	3.22	3.82	3.68	4.29
Ceftazidime	0.95	0.66	0.69	0.70	0.59	0.59	0.63	0.56	0.69
Cefepime	0.62	0.72	0.93	1.16	1.05	0.76	0.98	1.05	0.94
Meropenem (MER)	0.68	0.47	0.49	0.47	0.42	0.51	0.90	0.81	1.03
Imipenem (IMI)	1.14	0.99	1.18	0.94	0.86	1.39	1.30	1.43	1.43
Ciprofloxacin	6.25	5.31	5.07	5.73	5.67	6.14	6.02	5.91	5.98
Levofloxacin (LEV)	1.79	1.94	2.03	2.79	3.52	6.96	6.73	6.63	6.83
Overall antibiotics (ATC J01)	59.63	50.98	51.55	56.86	55.77	69.02	74.18	70.84	73.43
Number of cases of PA (N)	534	506	718	749	774	1126	1280	1250	Not available
%PA resistant to imipenem	12.90	14.70	15.60	15.60	11.70	14.10	14.70	11.40	14.20
%PA resistant to meropenem	7.40	6.70	6.50	7.70	6.30	11.30	12.70	9.30	11.40